secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLUS THERAPEUTICS, INC. (PSTV)
CIK:        0001095981
Form:       8-K
Filed at:   2025-03-10T23:59:59+00:00
Accession:  0001193125-25-050390
Event type: regulatory
Sentiment:  positive
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Plus Therapeutics regains Nasdaq minimum equity compliance after private placement
--------------------------------------------------------------------------------

- Received Nasdaq letter dated March 7, 2025 confirming compliance with minimum stockholders' equity requirement (Rule 5550(b)(1)).
- Compliance achieved via private placement disclosed on March 4, 2025; escrow funds now released to the company.
- Subject to Mandatory Panel Monitor until March 7, 2026; any future non-compliance triggers immediate delisting without cure period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1095981/000119312525050390/0001193125-25-050390-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1095981/000119312525050390/d938890d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-050390

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer